TRPA1 and Crohn disease: There is elevated expression of TRPA1 in fibrotic lesions from patients with Crohn’s disease, and activation of TRPA1 channels in myofibroblasts is associated with reduced intestinal fibrosis after treatment with prednisolone or pirfenidone [34].